BACKGROUND: The aim of this study was to monitor oropharyngeal bacterial colonization in patients indicated for percutaneous endoscopic gastronomy (PEG). METHODS: Oropharyngeal swabs were obtained from patients prior to PEG placement. A development of peristomal infection was evaluated. The analysis of oropharyngeal and peristomal site pathogens was done. RESULTS: Consecutive 274 patients referred for PEG due to neurological disorder or cancer completed the study. Oropharyngeal colonization with pathogens was observed in 69% (190/274), dominantly in the neurologic subgroup of patients (P < 0.001). Peristomal infection occurred in 30 (10.9%) of patients and in 57% of them the correlation between oropharyngeal and peristomal agents was present. The presence of oropharyngeal pathogens was assessed as an important risk factor for the development of peristomal infection only in oncological patients (OR = 8.33, 95% CI: 1.66-41.76). Despite a high prevalence of pathogens in neurological patients, it did not influence the risk of peristomal infection with the exception for methicillin resistant Staphylococcus aureus (MRSA) carriers (OR 4.5, 95% CI: 1.08-18.76). CONCLUSION: During oropharyngeal microbial screening prior to the PEG insertion, the detection of pathogens may be a marker of the increased risk of peristomal infection in cancer patients only. In neurological patients the benefit of the screening is limited to the detection of MRSA carriers.

Department of Clinical Microbiology University Hospital 625 00 Brno Czech Republic ; Department of Laboratory Methods Faculty of Medicine Masaryk University Brno 625 00 Brno Czech Republic

Department of Internal Medicine and Gastroenterology University Hospital and Faculty of Medicine Masaryk University Brno Jihlavska 20 625 00 Brno Czech Republic

Institute of Biostatistics and Analyses Faculty of Medicine Masaryk University 625 00 Brno Czech Republic

See more in PubMed

Gauderer M. Twenty years of percutaneous endoscopic gastrostomy: origin and evolution of a concept and its expanded applications. Gastrointestinal Endoscopy. 1999;50(6):879–883. PubMed

Löser C, Aschl G, Hébuterne X, et al. ESPEN guidelines on artificial enteral nutrition—percutaneous endoscopic gastrostomy (PEG) Clinical Nutrition. 2005;24(5):848–861. PubMed

Zopf Y, Konturek P, Nuernberger A, et al. Local infection after placement of percutaneous endoscopic gastrostomy tubes: a-prospective study evaluating risk factors. Canadian Journal of Gastroenterology. 2008;22(12):987–991. PubMed PMC

Lee C, Im JP, Kim JW, et al. Risk factors for complications and mortality of percutaneous endoscopic gastrostomy: a multicenter, retrospective study. Surgical Endoscopy. 2013;27(10):3806–3815. PubMed

Lipp A, Lusardi G. A systematic review of prophylactic antimicrobials in PEG placement. Journal of Clinical Nursing. 2009;18(7):938–948. PubMed

Blomberg J, Lagergren P, Martin L, Mattsson F, Lagergren J. Novel approach to antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG): Randomised controlled trial. BMJ. 2010;341(7763):p. 81.c3115 PubMed PMC

Sharma VK, Howden CW. Meta-analysis of randomized, controlled trials of antibiotic prophylaxis before percutaneous endoscopic gastrostomy. American Journal of Gastroenterology. 2000;95(11):3133–3136. PubMed

Jafri NS, Mahid SS, Minor KS, Idstein SR, Hornung CA, Galandiuk S. Meta-analysis: antibiotic prophylaxis to prevent peristomal infection following percutaneous endoscopic gastrostomy. Alimentary Pharmacology & Therapeutics. 2007;25(6):647–656. PubMed

Rey JR, Axon A, Budzynska A, Kruse A, Nowak A. Guidelines of the European Society of Gastrointestinal Endoscopy (E.S.G.E.). Antibiotic prophylaxis for gastrointestinal endoscopy. Endoscopy. 1998;30(3):318–324. PubMed

Banerjee S, Shen B, Baron TH, et al. Antibiotic prophylaxis for GI endoscopy. Gastrointestinal Endoscopy. 2008;67(6):791–798. PubMed

Allison MC, Sandoe JA, Tighe R, Simpson IA, Hall RJ, Elliott TSJ. Antibiotic prophylaxis in gastrointestinal endoscopy. Gut. 2009;58(6):869–880. PubMed

Mainie I, Loughrey A, Watson J, Tham TCK. Percutaneous endoscopic gastrostomy sites infected by methicillin-resistant Staphylococcus aureus: impact on outcome. Journal of Clinical Gastroenterology. 2006;40(4):297–300. PubMed

Thomas S, Cantrill S, Waghorn DJ, Mcintyre A. The role of screening and antibiotic prophylaxis in the prevention of percutaneous gastrostomy site infection caused by methicillin-resistant Staphylococcus aureus . Alimentary Pharmacology and Therapeutics. 2007;25(5):593–597. PubMed

Wertheim HFL, Melles DC, Vos MC, et al. The role of nasal carriage in Staphylococcus aureus infections. The Lancet Infectious Diseases. 2005;5(12):751–762. PubMed

Nicholas BD, Bhargave G, Hatipoglu A, Heffelfinger R, Rosen M, Pribitkin EA. Preoperative prevalence of methicillin-resistant Staphylococcus aureus (MRSA) colonization in patients undergoing intranasal surgery. Medical Science Monitor. 2010;16(8):CR365–CR368. PubMed

Rolston KVI, Mihu C, Tarrand JJ. Current microbiology of percutaneous endoscopic gastrostomy tube (PEG tube) insertion site infections in patients with cancer. Supportive Care in Cancer. 2011;19(8):1267–1271. PubMed

Mahadeva S, Sam I-C, Khoo B-L, Khoo P-S, Goh K-L. Antibiotic prophylaxis tailored to local organisms reduces percutaneous gastrostomy site infection. International Journal of Clinical Practice. 2009;63(5):760–765. PubMed

Ogundipe OA, Kar-Purkayastha S. An audit of antibiotics usage and their effect on MRSA infection or colonisation following percutaneous endoscopic gastrostomy in a district general hospital. International Journal of Clinical Practice. 2004;58(6):632–634. PubMed

Hansen D, Pollan LD, Fernando H. Fulminant clostridium difficile colitis: a complication of perioperative antibiotic prophylaxis. Journal of Oral and Maxillofacial Surgery. 2013;71(11):1880–1885. PubMed

Saadeddin A, Freshwater DA, Fisher NC, Jones BJM. Antibiotic prophylaxis for percutaneous endoscopic gastrostomy for non-malignant conditions: a double-blind prospective randomized controlled trial. Alimentary Pharmacology & Therapeutics. 2005;22(6):565–570. PubMed

Chuang CH, Hung KH, Chen JR, et al. Airway infection predisposes to peristomal infection after percutaneous endoscopic gastrostomy with high concordance between sputum and wound isolates. Journal of Gastrointestinal Surgery. 2009;14(1):45–51. PubMed

Ono H, Ito S, Yamazaki Y, Otaki Y, Otaki H. Effects of gastric acidity on peristomal infection after percutaneous endoscopic gastrostomy placement. Journal of Hospital Infection. 2010;76(1):42–45. PubMed

Richter-Schrag H, Richter S, Ruthmann O, Olschewski M, Hopt UT, Fischer A. Risk factors and complications following percutaneous endoscopic gastrostomy: A case series of 1041 patients. Canadian Journal of Gastroenterology. 2011;25(4):201–206. PubMed PMC

Grant DG, Bradley PT, Pothier DD, et al. Complications following gastrostomy tube insertion in patients with head and neck cancer: a prospective multi-institution study, systematic review and meta-analysis. Clinical Otolaryngology. 2009;34(2):103–112. PubMed

Faias S, Cravo M, Claro I, Lage P, Nobre-Leitaõ C. High rate of percutaneous endoscopic gastrostomy site infections due to oropharyngeal colonization. Digestive Diseases and Sciences. 2006;51(12):2384–2388. PubMed

Agha A, Alsaudi D, Furnari M, et al. Efficacy of 48-hour post-operative antibiotics prophylaxis for patients undergoing percutaneous endoscopic gastrostomy tube in preventing site infection. Journal of Gastrointestinal and Liver Diseases. 2011;20(2):131–134. PubMed

Radhakrishnan NV, Shenoy AH, Cartmill I, et al. Addition of local antiseptic spray to parenteral antibiotic regimen reduces the incidence of stomal infection following percutaneous endoscopic gastrostomy: a randomized controlled trial. European Journal of Gastroenterology and Hepatology. 2006;18(12):1279–1284. PubMed